Abstract

Meningococcal serogroup C (MenC) vaccination of men who have sex with men (MSM) was temporarily recommended to control an outbreak of invasive MenC disease among MSM in Berlin in 2012-2013. Vaccination was offered to HIV-infected MSM free of charge; others had to request reimbursement or pay out of pocket. We aimed to assess (i) awareness and acceptance of this recommendation through an online survey of MSM, (ii) implementation through a survey of primary care physicians and analysis of vaccine prescriptions, and (iii) impact through analysis of notified cases. Among online survey respondents, 60% were aware of the recommendation. Of these, 39% had obtained vaccination (70% of HIV-infected, 13% of HIV-negative/non-tested MSM). Awareness of recommendation and vaccination were positively associated with HIV infection, primary care physicians' awareness of respondents' sexual orientation, and exposure to multiple information sources. Most (26/30) physicians informed clients about the recommendation. Physicians considered concerns regarding reimbursement, vaccine safety and lack of perceived disease risk as primary barriers. After the recommendation, no further outbreak-related cases occurred. To reach and motivate target groups, communication of a new outbreak-related vaccination recommendation should address potential concerns through as many information channels as possible and direct reimbursement of costs should be enabled.

Highlights

  • Neisseria meningitidis (Nm) is a gram-negative diplococcus that commonly colonises the human pharynx and respiratory tract [1]

  • Acceptance and impact of a temporary meningococcal C (MenC) vaccination recommendation issued in response to a MenC outbreak among men who have sex with men (MSM) in Berlin in 2013

  • Our results show that repeated information via different sources led to higher vaccination uptake, similar to the findings of Friedman et al during a community-wide hepatitis A vaccination campaign [33]

Read more

Summary

Introduction

Neisseria meningitidis (Nm) is a gram-negative diplococcus that commonly colonises the human pharynx and respiratory tract [1]. Nm can sometimes cause invasive meningococcal disease (IMD), presenting as meningitis and/or sepsis. 13 serogroups have been identified; of these A, B, C, W, X and Y cause virtually all IMD [2]. Similar to other European and North American countries [3], serogroup B, followed by C, predominate in Germany, with IMD incidence showing a decreasing trend, from 0.95 cases/100,000 inhabitants in 2001 to 0.45/100,000 in 2011 [4]. Overall case fatality from 2009 to 2011 was 7.8%, significantly higher for meningococcal C (MenC) (10.9%) than for meningococcal B (MenB) disease (7.6%). Incidence was highest in infants (8.1 cases/100,000 inhabitants) and toddlers (4.8), with a second, smaller peak in 15-19 year-old adolescents (2.0) [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.